Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIGHT-IBD: Mirikizumab in Real World Settings for IBD
NCT07686757Phase 4Enrolling by invitation
- Sponsor
- Specialty Networks
- Start
- Aug 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 4 trial of mirikizumab in ulcerative colitis (UC), Crohn's disease, sponsored by Specialty Networks. Started Aug 2026; status: enrolling by invitation.
02
Drugs
mirikizumab
03
Conditions
ulcerative colitis (UC)Crohn's disease
Beyond the preview
Go deeper on NCT07686757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07686757.